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Abstract: A biomimetic approach involving the self-as-
sembly of mineral within the pores of three-dimensional
porous polymer scaffolds is a promising strategy to inte-
grate advantages of inorganic and organic phases into a
single material for hard tissue engineering. Such a mate-
rial enhances the ability of progenitor cells to differenti-
ate down an osteoblast lineage in vitro and in vivo, com-
pared with polymer scaffolds. The mechanisms regulat-
ing mineral formation in this one-step process, however,
are poorly understood, especially the effects of ionic ac-
tivity products (IP) of the mineralizing solution and incu-
bation time. The aims of this study were to define the
structure and composition of mineral formed within the
pores of biodegradable polymer scaffolds as a function of
IP and time. Three-dimensional poly(lactide-co-glycolide)
scaffolds were fabricated by solvent casting/particulate
leaching and incubated for 4–16 days in six variants of
simulated body fluid whose IPs were varied by adjusting
ionic concentrations. Scanning electron microscopy, X-ray
diffraction, and Fourier transform infrared spectroscopy
demonstrated the formation of carbonated apatite with
sub-micrometer sized crystals that grew into spherical
globules extending out of the scaffold pore surfaces. As
IP increased, more mineral grew on the scaffold pore sur-
faces, but the apatite became less crystalline and the Ca/
P molar ratio decreased from 1.63 6 0.005 to 1.51 6
0.002. Since morphology, composition, and structure of
mineral are factors that affect cell function, this study
demonstrates that the IP of the mineralizing solution is
an important modulator of material properties, poten-
tially leading to enhanced control of cell function.  2007
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INTRODUCTION
Apatites are suitable biomaterials for bone substi-
tution, repair, and regeneration because of their
osteoconductive and bioactive properties.1–5 How-
ever, the low mechanical properties of apatites pro-
hibit their use as bulk materials in many load-bear-
ing applications. To integrate the biological advan-
tages of these materials into functional biomaterials,
apatites have been used as coatings on metals,6–8
ceramics, glasses,9–13 and polymers,14–17 as well as a
second phase in polymer/ceramic composites.18,19
Different strategies to deposit surface layers of apa-
tite and create bone-bonding ability have been stud-
ied, including plasma spraying,20,21 ion sputter-
ing,22,23 and laser ablation.24,25 These techniques,
however, require high temperature treatments under
high vacuum, and are not suitable for coating poly-
mer substrates, which melt under those conditions.
The high temperatures of those processes also pro-
hibit the incorporation of biologically active factors.
Further, hydroxyapatite (HAp) that has been ex-
posed to a heat treatment exhibits high crystallinity,
resulting in a structure and properties that differ
from bone.26,27
A biomimetic process can provide simple and
favorable conditions (e.g., body temperature and
atmospheric pressure) for the synthesis of bone-like
apatite. In such strategies, apatite self-assembles onto
a substrate during incubation in simulated body
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fluid (SBF), a supersaturated solution, whose ionic
concentrations are similar to blood plasma.14,15,28–30
The apatite formed by this method is similar to bone
mineral in composition and crystallinity.14,31 This
bone-like apatite is therefore expected to provide a
better environment for bone cell attachment and pro-
liferation than sintered stoichiometric HAp, since
most bone mineral is nonstoichiometric carbonated
apatite (CAp).32 Mineral formation via this aqueous
process is governed by both surface characteristics of
the substrate and incubating parameters, such as so-
lution composition, ionic strength, pH, and tempera-
ture, as well as incubation time.33
Hard tissue engineering requires scaffolds to guide
and promote controlled cellular growth and differen-
tiation. Poly(lactide-co-glycolide) (PLGA) is one of
the polymers used because of its controllable biode-
gradability and biocompatibility.34 Key characteristics
of PLGA scaffolds include sufficient porosity and
interconnectivity between the pores, to facilitate cell
proliferation, influx of biomolecules and nutrients,
efflux of wastes, and vascularization. PLGA scaffolds
by themselves, however, exhibit poor osteoconductiv-
ity and low mechanical properties.14
To compensate for these design deficiencies, three-
dimensional porous PLGA scaffolds have been
hybridized with inorganic coatings by mineralization
in SBF.14,29,35,36 One of the unique qualities of PLGA
is that functional groups that chelate Ca ions can
be created by simple hydrolysis, without the need
for a separate functionalization step or surface pre-
treatment. Therefore, self-assembly of mineral onto
PLGA substrates can be achieved via a one-step pro-
cess, in which samples are both hydrolyzed and
mineralized in SBF. Surface-mineralized PLGA ex-
hibits enhanced mechanical properties, yet retains
the high porosity of the polymer scaffold.14 In addi-
tion, in vitro (cell proliferation, osteoblast differentia-
tion, and cytoskeletal organization) and in vivo (vol-
ume fraction of regenerated bone) functions of osteo-
blast precursor cells are enhanced on mineralized
surfaces compared with their polymeric counterparts
in both two and three dimensions.35,37
Even though the mineralized layer of these com-
posites is the surface on which interactions with cells
occur, there is only limited information on the struc-
ture and composition of the mineral formed within
the pores of three-dimensional polymer scaffolds as
a function of processing parameters. We therefore
investigated the regulation of the structure and com-
position of the mineral formed within the pores of
three-dimensional PLGA scaffolds by varying the
ionic activity product (IP) of the incubating solution
and incubation time. Changes in morphology, chemi-
cal composition, and structure of the mineralized
surfaces of the scaffolds were analyzed by scanning
electron microscopy (SEM), X-ray diffraction (XRD),
Fourier transform IR (FTIR), and optical emission
spectrometry (OES).
MATERIALS AND METHODS
Synthesis of polymer scaffolds
PLGA with a lactic/glycolic acid ratio of 85/15 (Medi-
sorb, Cincinnati, OH) and chloroform (Sigma-Aldrich,
St. Louis, MO) were used for preparing three-dimensional
scaffolds by a solvent casting, particulate leaching process,
as previously described.14 NaCl (Sigma-Aldrich) particles
were sieved in the range of 250–425 lm to dictate the pore
size in the scaffolds. The disk-shaped scaffolds were fabri-
cated to a thickness of 3 mm and a diameter of 13 mm.
Mineralization of polymer scaffolds
SBF with different IPs were prepared by changing ionic
concentrations (Table I). Each solution was prepared by
dissolving reagent-grade chemicals (NaCl, KCl, MgSO4,
MgCl2, NaHCO3, CaCl2, KH2PO4) (Sigma-Aldrich) into
deionized water. To maintain thermodynamic conditions
conducive to heterogeneous nucleation and control the
ionic solubility such that solutions were supersaturated,
SBFs were buffered to three different pH values (7.4 for
0.75–1.00 3 SBF, 7.0 for 1.25–1.50 3 SBF, or 6.8 for 1.75–
2.00 3 SBF) at 378C with Tris-HCl (Sigma-Aldrich) and 1N
NaOH solution. Tris-HCl solution was buffered to pH 7.4
for control groups. All the SBFs and Tris-HCl solutions
were sterilized through 0.22-lm nylon filter before use.
Each scaffold was immersed in 60 mL of SBF solution at
378C, which was renewed every 24 h to ensure constant
initial IPs. After 4, 8, 12, and 16 days of incubation, the
mineralized samples were gently rinsed in deionized water
and dried in a vacuum drier at room temperature.
Characterization of mineral
The mass of each scaffold was determined before incu-
bation and after 4, 8, 12, and 16 days of immersion. Mor-
phological changes of the PLGA pore surface and the min-
eral formed within the scaffolds were analyzed by SEM
(Philips XL30 FEG SEM), operating at 15 kV. Specimens
were bisected and sputter-coated with gold before SEM ex-
amination. Formation of mineral crystals on the scaffolds
was determined by XRD (TF-XRD, Rigaku). To avoid alter-
ing the properties of the mineral, the mineral layer was
not separated from the surface of the PLGA scaffold. The
whole mineralized scaffold was adhered on a sample
holder along the X-ray incident direction and scanned in
the 2h range of 5–608 with a scanning step of 0.018 at 28/
min, which is a proper scanning speed for the characteri-
zation of apatite formed from SBFs.29,38 Cu Ka radiation
was used for the diffraction with a voltage of 40 kV and a
current of 100 mA. As references, HAp (Sigma-Aldrich
No. 289396) and CAp with 6 wt % of CO3
2 (generous gift
from Dr. Michael Morris at the University of Michigan)
were scanned under the same conditions.
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Compositional analyses via FTIR were carried out on a
Perkin Elmer Spectrum BX FTIR in the wave number
range of 2000–400 cm1. PLGA scaffolds with and without
mineral were ground into fine particles, mixed with KBr
(FTIR grade) at a mass ratio of 100:1, and compressed into
a pellet at 6.89 3 104 kPa. To verify the composition of the
mineral on the surface of the scaffold, the mineral layer
was dissolved in a 1N HCl solution for 24 h and analyzed
with OES to obtain molar ratios of calcium and phospho-
rus. After every 24-h incubation period, the SBF was also
sampled, acidified with HNO3, and subjected to the OES
to calculate the daily consumption of each element.
Samples sizes and statistical analyses
For quantitatively determining changes in mass and
Ca/P ratio, five scaffolds were prepared for each of the
SBF groups and control groups at each of the incubation
times. For analyzing ion transfer from solution to scaffold,
SBFs used for 24-h incubation were collected from five
separate containers of each group. Two-way ANOVAs
were used to analyze effects of time and IP on mass
change and Ca/P ratio. The Holm–Sidak method was cho-
sen for pair-wise multiple comparisons. Differences were
considered significant if p < 0.05.
RESULTS
IP determines rate of mineralization
Altering the IP of the mineralizing solutions led to
differences in the amount and rate of mineralization
during the one-step mineralization process (Figs. 1
TABLE I
Concentrations (mM) of Ions and Ionic Activity Products (IP) of Human Blood Plasma and the Simulated
Body Fluids (SBF) Used in this Study
Naþ Kþ Mg2þ Ca2þ Cl HCO3
 H2PO4
 SO4
2 log IP pH
Blood plasma 142.0 5.0 1.5 2.5 103.0 27.0 1.0 0.5 96.3 7.2–7.4
0.75 3 SBF 105.8 3.8 1.1 1.9 114.0 3.2 0.8 0.4 98.3 7.4
1.00 3 SBF 141.0 5.0 1.5 2.5 152.0 4.2 1.0 0.5 96.3 7.4
1.25 3 SBF 175.3 6.3 1.9 3.1 190.0 5.3 1.3 0.6 95.6 7.0
1.50 3 SBF 211.5 7.5 2.3 3.8 228.0 6.3 1.5 0.8 94.3 7.0
1.75 3 SBF 246.8 8.8 2.6 4.4 266.0 7.4 1.8 0.9 93.7 6.8
2.00 3 SBF 282.0 10.0 3.0 5.0 304.0 8.4 2.0 1.0 92.8 6.8
Figure 1. SEM images of the pore surfaces of (a) a PLGA scaffold before mineralization, and a scaffold mineralized in
2.00 3 SBF at (b) day 8, (c) day 12, and (d) day 16. At a given ionic activity product, the amount of mineralization
increases with incubation time. Inset in (d) shows flake-like structure of mineral at higher magnification.
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and 2), but the minerals formed from solutions of all
IP exhibited similar morphologies of sub-micrometer
sized flake-like apatite (Fig. 3). During the first 8 days
of incubation, in solutions of all IP, most of the surface
area of the scaffolds was unaltered and was similar to
the pore surfaces of the PLGA scaffolds before incuba-
tion [Fig. 1(a,b)]. Mineral deposition, however, was
accelerated following day 8. From all solutions, except
0.75 3 SBF, mineral accumulated in a radial pattern,
which grew into spherical globules extending out of
the plane of the pore surfaces by days 12 and 16 [Fig.
1(c,d)]. At a given time, as IP increased, more mineral
was observed on the pore surfaces of the scaffolds
(Fig. 2). At day 16 of incubation, the entire pore surfa-
ces of the scaffolds incubated in high IP solutions
(1.50–2.00 3 SBF) were coated with mineral globules
that merged to form continuous layers [Fig. 2(d–f)].
On the other hand, scaffolds incubated in lower IP sol-
utions (1.00 3 SBF and 1.25 3 SBF) were only partially
mineralized [Fig. 2(b,c)]. Mineralization was rarely
observed on scaffolds incubated at the lowest IP (0.75
3 SBF) [Fig. 2(a)].
Mass change due to ion transfer varies
with IP and incubation time
The amount of mineralization, as determined by
percent increase in mass over time, increased signifi-
cantly with both incubation time (p < 0.001) and IP
(p < 0.001) (Fig. 4). No significant increase in mass
occurred before day 8 in any IP group. In higher IPs
Figure 2. SEM images of scaffold surfaces after 16 day incubation in (a) 0.75 3 SBF, (b) 1.00 3 SBF, (c) 1.25 3 SBF, (d)
1.50 3 SBF, (e) 1.75 3 SBF, and (f) 2.00 3 SBF. At a given incubation time, the amount of mineralization increases with
increasing ionic activity product.
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(1.25–2.00 3 SBF), significant increases in mass
occurred between days 8 and 12, and 12 and 16 (p <
0.05). Within the two lowest IP groups, scaffold
mass did not significantly change over 16 days. The
percent change in mass between any two IPs, as
well as between mineralized samples and controls,
had statistical significance at 12 and 16 days (p <
0.01 at both times).
Transfer of Ca and P occurred nonlinearly from
the SBF to the surfaces of the scaffolds (Fig. 5), and
Figure 3. Highly magnified nanoscale structures of the minerals after 16 day incubation in (a) 1.25 3 SBF, (b) 1.50 3
SBF, (c) 1.75 3 SBF, and (d) 2.00 3 SBF.
Figure 4. Mass increases relative to time zero values for
scaffolds incubated in deionized water þ Tris-HCl (^),
0.75 3 SBF (~), 1.00 3 SBF (l), 1.25 3 SBF (n), 1.50 3
SBF (~), 1.75 3 SBF (*), and 2.00 3 SBF (&).
Figure 5. Ion concentrations of residual Ca and P in 2.00
3 SBF after being used for 24 h.
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this supports the nonlinear increases in mass with
time. Initial concentrations of Ca and P in 60 mL of
2.00 3 SBF were 5.0 and 2.0 mM, respectively (Table
I). For the first 4 days, Ca and P atoms were not
depleted from SBF. Between days 5 and 9, the
amount of atomic depletion increased, which indi-
cates mineral formation resulting from the consump-
tion of Ca and P atoms in SBF. After day 9, con-
sumption of Ca and P ions from solution continued,
but at a lower rate than between days 5 and 9.
IP affects crystallinity of the apatite
After 16 days of incubation, all of the mineralized
layers had structures of apatite, but different crystal-
linities, depending on the ionic products of the SBFs
(Fig. 6). All XRD results were normalized to the in-
tensity of the broad hump of PLGA at 178. In all
apatites, peaks were observed between 31.4 and
32.28, corresponding to either (211) of HAp or (112)
of CAp apatite, and at 45.48, corresponding to (203)
of HAp.39 Peaks between 31.4 and 32.28 were shifted
to higher wavenumber and broadened. Peak shift
and broadening result from phase transition and/or
strain. As the apatites in this study were formed
from static solutions, it is reasonable to assume that
peak changes resulted from phase transition rather
than strain. However, phase transition between HAp
and CAp cannot be clearly determined with XRD,
because peak positions of HAp and CAp are very
close to each other or overlap.39 It is especially diffi-
cult to differentiate diffraction patterns of CAp from
HAp when the CO3
2 content is low (Fig. 6, reference
peaks).40 The CO3
2 contents of the groups shown in
Figure 6 were between 5.42 and 7.23 wt % (calcula-
tion method is described in the following FTIR result
section). Carbonation, however, is more clearly con-
firmed by FTIR analysis (Fig. 7).
Apatite formed from low IP SBF (0.75 3 SBF)
showed sharp peaks, indicating high crystallinity,
whereas comparatively broader peaks were exhibited
in the apatites formed from high IP SBFs, indicating
low crystallinity. Since full-width-at-half maximum
(FWHM) is one of the parameters most widely used
as an indicator of apatite crystallinity,41 FWHM of
the most intense peak [either (211) of HAp or (112)
of CAp] was measured as a relative gage of crystal-
linity between sample groups. Peak width, however,
was not in direct proportion to the IPs of SBFs
(FWHM values: 0.75 3 SBF, 0.294; 1.0 3 SBF, 0.147;
1.25 3 SBF, 0.147; 1.5 3 SBF, 0.147; 1.75 3 SBF,
0.294; 2.0 3 SBF, 1.035).
IP influences chemical composition of apatite
over time
Solution IP, as well as incubation time, affected
the composition of the mineralized scaffolds (Fig. 7).
The absorption bands were characterized based on
the studies of synthetic and biological apatites.27,42–45
Band intensities of CO3
2 increased with increasing
IP and incubation time [insets in Fig. 7(a–d)]. As the
band intensities of CO3
2 are weak at days 4 and 8, it
is permissible to use m3 (1630 and 1551 cm
1) of
CO3
2 for assigning IR on calcium phosphates, since
the m1 CO3
2 band (1430 cm1) and m4 CO3
2 band
(1454 cm1) are masked by the bands from PLGA
(1419 and 1456 cm1) [Fig. 7(a,b)].45 On days 4 and 8
of incubation, CO3
2 bands at 1630 and 1551 cm1
(m3), denoted by hollow squares (&), were more evi-
dent on the scaffolds mineralized in higher IP solu-
tions [insets in Fig. 7(a,b)]. As the CO3
2 band at 873
cm1 (m3) also overlaps with a band from the PLGA
control (867 cm1), this band was not clearly distin-
guished at days 4 and 8 [Fig. 7(a,b)], and became
evident only in the highest IP (2.00 3 SBF) at days
12 and 16 [insets in Fig. 7(c,d)].
PO4
3 bands at 1037 (m3), 960 (m1), 602 (m4), and 563
cm1 (m4), denoted by solid circles (l), were detected
on scaffolds incubated in higher IP solutions at all
times, but showed increases in intensity following 12
and 16 days of incubation in 1.25–2.00 3 SBFs
[Fig. 7(c,d)], which indicated that PO4
3 groups
became involved in mineral formation. At days 12
Figure 6. X-ray diffraction patterns of the mineralized
pore surfaces of the PLGA scaffolds after 16-day incuba-
tion in simulated body fluids of different ionic activity
product. Apatite formed from low IP SBF (0.75 3 SBF)
showed sharp peaks, indicating high crystallinity, whereas
comparatively broader peaks were exhibited in the apatites
formed from high IP SBF (2.00 3 SBF) indicating low crys-
tallinity.
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and 16 of incubation, more vivid CO3
2 bands were
present at 1457 (m3b of type B CAp) and 1419 cm
1
(m3a of type B CAp) indicating that a larger percent-
age of the CO3
2 was type B carbonate, in which
CO3
2 replaces PO4
3 in the apatite structure [insets
in Fig. 7(c,d)]. From the FTIR analysis (Fig. 7), the
CO3
2 content was calculated by using a correlation
between the ratio of a CO23 absorption band at 1420
cm1 (m1) to a PO
3
4 absorption band at 600 cm
1 (m4)
and known CO3
2 wt %.40 At day 16, the CO3
2 con-
centration of the apatite was inversely proportional
to IP (CO3
2 wt %: 1.25 3 SBF, 7.23; 1.5 3 SBF, 6.15;
1.75 3 SBF, 5.80; 2.0 3 SBF, 5.42).
The Ca/P ratios of the mineral decreased from
1.63 6 0.005 to 1.51 6 0.002 with increasing IP
(Fig. 8). At both days 12 and 16, there was a signifi-
cant effect of IP, with a significant decrease in Ca/P
occurring between successively greater IPs (p <
0.01). Within each IP, there was no effect of time on
Ca/P between days 12 and 16.
DISCUSSION
The formation of mineral on substrates incubated
in solutions of different IP is dependent on incubation
time, and the rate of mineralization can be accelerated
by increasing IP. Mineralization of a polymer sub-
strate has two distinct stages, as does mineralization
Figure 7. FTIR spectra of the mineralized pore surfaces of PLGA scaffolds as a function of ionic activity product at day
4(a), 8(b), 12(c), and 16(d). Band intensities of phosphate and carbonate increased with ionic activity product and incuba-
tion time. At longer incubation times, more type B carbonate formed. Bands within dotted boxes were stacked, enlarged,
and inserted to present changes in CO23 [insets in Fig. 7(a–d)]. [Color figure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
1082 SHIN, JAYASURIYA, AND KOHN
Journal of Biomedical Materials Research Part A DOI 10.1002/jbm.a
in vivo.32 Initially, following surface hydrolysis, min-
eral nucleation occurs on the polymer surface (pri-
mary nucleation) and then additional mineral crystals
grow on the nucleated mineral (crystal growth). For
PLGA substrates, surface hydrolysis, primary nuclea-
tion, and growth occur in an efficient, single-step
treatment in SBF without the need for a separate
functionalization step or surface pretreatment in
water or NaOH. For initiating primary nucleation on
a PLGA scaffold, a combination of conditions is
required; hydroxyl groups and hydrophilic carboxylic
acid should be provided from ester bond scission in
the carbon backbone of the PLGA, and a large
amount of ions should be locally accumulated around
the scaffold.
At day 4, the polymer surfaces did not exhibit
any morphological changes indicative of primary
nucleation and were similar to the nonmineralized
control samples. Ion depletion of SBF due to pri-
mary nucleation was not observed either during the
first 4 days of incubation (Fig. 5). However, there
were changes in FTIR spectra for scaffolds incubated
in higher IP solutions at day 4 (Fig. 7), indicating
some ionic binding to the polymer surface. This
finding is, however, likely the result of a highly
localized existence of a small amount of nuclei,
rather than coverage of a large percentage of the
pore surfaces with mineral. These trends imply that
IP has little effect on reducing the time for surface
hydrolysis, which is in accord with the fact that sur-
face hydrolysis of PLGA occurs by the water mole-
cules in SBF. After surface hydrolysis and mineral
nucleation, less energy and time are required to add
ions or ion clusters to already existing mineral
nuclei than are required to form the initial mineral
crystals.32 SBFs with higher IP can provide more
accumulated clusters of calcium, CO3
2, and PO4
3
ions around a scaffold, which eventually lead to dif-
ferences in the rate of the mineral growth, compared
with SBFs with a low IP.
The morphology of the apatite formed from SBF is
determined by parameters of the fluid, including
Ca/P molar ratio,46 and concentrations of Mg2þ, F,
and HCO3
.47,48 In this study, there were no morpho-
logical differences between apatites formed from sol-
utions of different IP. This could be due to the con-
stant Ca/P molar ratio of 2.5/1 and the constant
fraction of Mg2þ and HCO3
 in all solutions. Use of
three different pH values of SBF, depending on IP,
to maintain heterogeneous nucleation, did not lead
to changes in mineral morphology. Generally, SBFs
with higher IPs (e.g., 5 3 SBF) are either buffered to
mildly acidic pH values (e.g., 5.8 or lower) and/or
contacted with an acidic gas-like carbon dioxide,
since increasing IP of SBF is limited by the low solu-
bility of Ca–P salts.36,49–51 Under conditions of high
IP and low pH of an SBF, a rapid increase in pH is
observed, along with homogeneous nucleation in the
solution, which can also lead to changes in apatite
morphology with pH.49 However, within the nar-
rower and more physiological pH range used in this
study (6.8–7.4), the morphology of the apatite was
not affected by pH, at either the macro- or micro-
scales (Fig. 3).
All of the apatites were flake-like and composed
of sub-micrometer sized structures (Fig. 3). These fea-
tures are distinct, compared with previous studies,
in which micrometer-sized plate-like structures were
reported.47–49 Differences in the size and shape of
the mineral structure reported by others could be
because of compositional differences in SBFs, in
which either only reagents containing Ca and P
were doubled,31 or lack of crystal growth inhibitors,
such as Mg2þ and HCO3
, resulting in higher Ca–P/
inhibitor ratios than that we used.47,48 Inhibitors
such as Mg2þ and HCO3
 interfere with the forma-
tion of a Ca–P complex and can lead to the forma-
tion of a poorly crystallized Ca-deficient apatite.48
All of the minerals synthesized in this study were
type B CAps, and their compositions were depend-
ent on IP. Although the Ca/P molar ratios of the
SBFs were kept constant at 2.5, the Ca/P molar ratio
of the apatite increased from 1.51 to 1.63 as IP
decreased, compared with the apatite in bone, which
has a Ca/P ratio of 1.57–1.62. The monotonic de-
crease in Ca/P ratio with increasing IP could be
because of the inverse correlation between substitu-
tion of CO3
2 and IP. Since substitution of a trivalent
ion (PO4
3) by a bivalent ion (CO3
2) should leave a
Figure 8. Ca/P ratio of the mineralized layers formed
from six different simulated body fluids at days 12 and 16.
Asterisks denote significant differences in Ca/P between
different ionic activity products at both 12 and 16 days.
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negative residual electric charge in the unit cell of an
apatite, one substitution of CO3
2 ion for PO4
3 ion
results in a half Ca and one P deficiency, which
leads to the increase in the Ca/P molar ratio.40 FTIR
data show that relatively more PO4
3 ions were
incorporated with CO3
2 ions in apatites incubated in
higher IP, which indicates that the substitution of
CO3
2 ion for PO4
3 ion in the apatite structure arose
more readily in low IP solutions. This interpretation
of phase transition between the HAp and the CAp is
supported by the calculated concentrations of CO3
2,
which showed CO3
2 wt % is inversely proportional
to IP. Ca/P molar ratios achieved in this study make
these materials suitable for biological purposes, as
calcium phosphate with Ca/P ratios in the range
1.50–1.67 yields the most beneficial tissue
responses.52,53
The long period of incubation required for com-
plete mineralization of the pore surfaces in this one-
step process was mainly because of the slow surface
hydrolysis of the PLGA. To achieve faster hydroly-
sis, pretreatment of metals8,54 and polymers17,29,31
with water or an alkaline solution, such as NaOH,
has been introduced. This alkaline treatment, how-
ever, needs to be carried out on polymer substrates
without compromising polymer integrity.17,31 Since
polymers such as PLGA degrade in a basic solution,
the concentration of NaOH and pretreatment time
should be carefully determined so that only the sur-
faces of the PLGA pores become hydrolyzed to
induce faster mineralization, but the scaffold itself
maintains mechanical stability. Therefore, when de-
signing hydrolysis processes, geometric parameters
of the scaffolds, such as porosity and thickness, also
need to be considered. Pretreatment in 0.2N NaOH
solution for 30 min was suitable for the scaffolds
used in this study. After 4 days of incubation in 1 3
SBF, the alkaline pretreated scaffolds were mineral-
ized as much as non-pretreated ones were on day
12, and the mass loss of alkaline-treated scaffolds
was not significantly different from scaffolds
exposed to just deionized water (data not shown).
More importantly, this pretreatment did not affect
any properties of the apatite (e.g., morphology, com-
position) formed by the biomimetic process. Another
strategy to accelerate mineralization is to use a more
concentrated SBF.36,50,51 However, occlusion of pores
in more closed cell porous structures, such as scaf-
folds formed from salt leaching, is a possibility.
We previously developed a system in which three-
dimensional porous PLGA scaffolds self-assemble a
bone-like mineral extracellular matrix analogue us-
ing one type of SBF.14,35,37 The features of this min-
eral are consistent with biological apatite in terms of
its mineral morphology, chemical composition, Ca/P
molar ratio, and low crystallinity. Compared with
nonmineralized PLGA scaffolds, this hybrid sub-
strate led to significantly enhanced cell adhesion, dif-
ferentiation, and cytoskeletal organization in
vitro.35,37 When bone marrow stromal cells were
seeded on mineralized scaffolds and transplanted
into mice, a significantly higher volume fraction of
regenerated bone was achieved compared with non-
mineralized PLGA controls, supporting the hypothe-
sis that a biomimetic microenvironment will enhance
cell differentiation and increase bone formation.35
Substrate mineralization also causes expression of
different cell adhesion contacts and modifies cell mo-
tility.37 For critical-size calvarial defects, apatite-
coated PLGA leads to bone regeneration with a high
mineral density, whereas uncoated PLGA scaffolds
do not.55 In addition, partial dissolution of the apa-
tite can increase Ca and P ion concentrations in the
local environment and cause solution-mediated
effects on cell function.56 Altering crystallinity and
Ca/P ratio of the mineral, as we have demonstrated
in these studies, may therefore lead to adjustable dis-
solution rates, which can control solution-mediated
effects, as well as delivery of growth factors or other
biomolecules.
In the present study, we demonstrated that the IP
of an SBF is an important and useful factor to modu-
late properties of bone-like apatite coated on three-
dimensional PLGA scaffolds. This approach showed
that material properties of the apatite, such as mor-
phology, crystallinity, CO3
2 content, and Ca/P ratio
can be controlled in a predictable manner by adjust-
ing only the IP of a mineralizing solution. It is, how-
ever, still unclear what physical–chemical properties
of apatite are required to optimize cell functions.57
One consensus finding could be that the enhanced
biological responses can be achieved only when a
material provides similar properties to bone apa-
tite.52,53,56 Apatites formed from the solutions with
six different IPs of this study presented features sim-
ilar to bone apatite in terms of the apatite phase
(CAp), the Ca/P ratio (1.57–1.62), and the CO3
2
content (5.42–7.23 wt %). By changing IPs and time
of incubation in mineralizing solutions it therefore
becomes more feasible to manipulate the chemical
and structural properties of the mineral coating on
the surface of a polymer scaffold, and this is
expected to be able to further modulate biological
functions.
We thank the University of Michigan Electron
Microbeam Analysis Laboratory (EMAL) for use of the
SEM.
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